<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01241994</url>
  </required_header>
  <id_info>
    <org_study_id>106/2004/U/Oss</org_study_id>
    <nct_id>NCT01241994</nct_id>
  </id_info>
  <brief_title>Automatic Adaptive System Dialysis (AASD)</brief_title>
  <official_title>Automatic Adaptive System Dialysis (AASD) for Dialysis Related Hypotension and Intolerance: a Prospective Long-term Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Azienda Ospedaliero-Universitaria di Bologna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Azienda Ospedaliero-Universitaria di Bologna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      AASD is a new dialysis technique based on the use of a mathematical model of intradialytic&#xD;
      solutes and fluid kinetic, for the automatic elaboration of dialysate sodium and&#xD;
      ultrafiltration rate profile. The aim of dialysate sodium and ultrafiltration rate profile is&#xD;
      to obtain the higher stabilization of intradialytic extra cellular compartment, in&#xD;
      consideration of end session targets: body weight and final patient's natremia. In this&#xD;
      multicenter prospective controlled randomized trial the primary end-point is the clinical&#xD;
      efficiency validation of AASD on intradialytic hypotension but also on thirst, cramps,&#xD;
      headache, nausea, vomiting, hypotensive events observed in basal treatment (HD or HDF).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>number of intradialytic hypotensive events</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>percentage of dysequilibrium symptoms</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Dialysis Intolerance</condition>
  <arm_group>
    <arm_group_label>basal hemodialysis</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>AASD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>AASD dialysis technique</intervention_name>
    <arm_group_label>AASD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:Patients in HD/HDF (bicarbonate dialysis/hemodiafiltration) for at least&#xD;
        6 months&#xD;
&#xD;
          -  aged more than 18 years&#xD;
&#xD;
          -  on chronic thrice-weekly HD&#xD;
&#xD;
          -  symptomatic hypotension during at least 30% of dialysis sessions on basal treatment in&#xD;
             the last month before admission or/and 1 hypotension /week&#xD;
&#xD;
          -  disequilibrium symptoms (cramps, headache, nausea, vomiting, hypotensive events) in at&#xD;
             least 30% of dialysis sessions on basal treatment&#xD;
&#xD;
          -  dialysis session time: 4 hours (as much as possible)&#xD;
&#xD;
          -  Signed inform consent form&#xD;
&#xD;
          -  Patients having no vascular access related problems (bi-ponction, blood flow rate&#xD;
             300ml/min)&#xD;
&#xD;
        Exclusion Criteria: Patients in a pregnant state&#xD;
&#xD;
          -  Patients whose life expectancy is less than study period&#xD;
&#xD;
          -  Patients with progressive acute pathology (neoplasia…)&#xD;
&#xD;
          -  Patients included in an other protocol&#xD;
&#xD;
          -  Psychiatric patients or patients unable to consent or unable to follow the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>policlinico S. Orsola</name>
      <address>
        <city>Bologna</city>
        <zip>40100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Colì L, Ursino M, Dalmastri V, Volpe F, La Manna G, Avanzolini G, Stefoni S, Bonomini V. A simple mathematical model applied to selection of the sodium profile during profiled haemodialysis. Nephrol Dial Transplant. 1998 Feb;13(2):404-16.</citation>
    <PMID>9509454</PMID>
  </results_reference>
  <results_reference>
    <citation>Ursino M, Colì L, Brighenti C, De Pascalis A, Chiari L, Dalmastri V, La Manna G, Mosconi G, Avanzolini G, Stefoni S. Mathematical modeling of solute kinetics and body fluid changes during profiled hemodialysis. Int J Artif Organs. 1999 Feb;22(2):94-107.</citation>
    <PMID>10212044</PMID>
  </results_reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 15, 2010</study_first_submitted>
  <study_first_submitted_qc>November 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2010</study_first_posted>
  <last_update_submitted>March 17, 2021</last_update_submitted>
  <last_update_submitted_qc>March 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2021</last_update_posted>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

